Academics
Degree | University/Institution |
---|---|
Ph.D. |
Work Experience
Position | University/Organisation | Period |
---|---|---|
Scientist |
Awards & Recognition
Details |
---|
. |
Research
Details |
---|
Very broadly my laboratory is interested to understand Immunobiology of infectious diseases such as Malaria, Filariasis and Sepsis. We use a variety animal models and human diseases to seek insights into pathogenesis of disease processes, analysis of parasite components that induce host responses (inflammation and adaptive immune response), immunoregulatory network that determine pathology and/or outcome of infection process. More specifically, we characterize host response in the context of co-infections in animal models and in human communities. The experimental model allows us to understand effect of two pathogens with opposing immune response in the host. The other major project in the laboratory is directed towards inflammation mediated by pathogens and endogenous molecules broadly classified as DAMPs and the interplay and cross-talk between the two. We expect these studies to offer insights into how mammalian hosts ‘deal’ with pathogens and non-pathogenic commensal microbes. Our studies on regulation of inflammation and innate immunity have also led us into understanding macrophage biology and approaches to re-programme macrophage activity in inflammatory diseases. Our investigations on co-infections in human communities have given us opportunities to address genetic basis of infectious diseases and relationship between some of the infectious diseases and autoimmunity. One of the issues that has been addressed in greater detail is Plasmodium and SARS CoV-2 coinfections. It was resolved that past infections with Plasmodium offer in human ACE2 Tg mice offers resistance against mortality without affecting the viral load in lungs when challenged with a virulent strain of SARS CoV-2 The major current interest of the laboratory has been on regulation of Nitric Oxide production by Nitric Oxide synthases by Nitric Oxide Interacting proteins (NOSIP) and discovery of small molecules that function as NOSIP antagonists and block interaction between NOSIP and NOS thus enhancing endogenous levels of Nitric Oxide. The possibility of developing these small molecules as chemotherapeutic drugs for management of hypertension, type 2 diabetes, anti-microbials to combat AMR, inflammation etc., A spin off company of ILS Byonox Pvt Ltd has been floated for commercial development of NOSIP antagonists. |
Publications
Details |
---|
135 + International Research papers, reviews and 9 Patents ORCID https://orcid.org/0000-0001-7399-0285 https://scholar.google.com/citations?user=nq8jKmQAAAAJ&hl=en Some of the salient publications:
|
Group
Details |
---|
Immunobiology of metazoan parasites Group Members Collaborators Dr. Satyajit Rath, NII, New Delhi |
Grants
Details | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunobiology of metazoan parasites
|
Contacts
Address | Fax | Office | |
---|---|---|---|
balaravi@ils.res.in | Institute of Life Sciences Nalco Square, Bhubaneswar-751023, India | 0091 674 2300728 | 0091 674 2300137/ 2301476 ext. 204 |
Highlights
Details |
---|
Danger Demystifiedhttps://ils.res.in/DangerDemystified.pdf |
Positions
Details |
---|
|